Biotechnology New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack) May 3, 2022
Biotechnology Apellis Announces Dr. Peter Hillmen, Renowned Hematologist and PNH Expert, to Join Company May 3, 2022
Biotechnology Editas Medicine to Present Pipeline and Platform Data Demonstrating Progress Towards Developing Transformative Gene Editing Medicines at the American Society of Gene and Cell Therapy Annual Meeting May 2, 2022
Search
Biotechnology
